Seer to Participate in the Piper Sandler Virtual Healthcare Conference
November 22 2021 - 8:05AM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that the
company will participate in the Piper Sandler 33rd Annual Virtual
Healthcare Conference. A pre-recorded presentation will be
available on the conference website beginning on November 22, 2021.
A link to the presentation will also be available on the Investors
section of the company’s website at investors.seer.bio.
Seer will be participating in investor meetings
at the Piper Sandler Healthcare Conference on Wednesday, December
1, 2021 and Thursday, December 2, 2021.
About SeerSeer™ is a life
sciences company developing transformative products that open a new
gateway to the proteome. Seer is commercializing its Proteograph™
Product Suite, an integrated solution that includes proprietary
engineered nanoparticles, consumables, automation instrumentation
and software to perform deep, unbiased proteomic analysis at scale
in a matter of hours. Seer designed the Proteograph workflow to be
efficient and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren
Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024